Medscape (8/29) reports that “a new integrated program for treating depression in cancer patients is reported to be ‘strikingly more effective’ at both reducing depressive symptoms and improving quality of life than the current standard of care.” This “approach, known as Depression Care for People with Cancer (DCPC), was tested in 2 clinical trials: the SMaRT-2 study, reported in the Lancet , and the SMaRT-3 study, reported in the Lancet Oncology.”
Related Links:
— Medscape (requires login and subscription)